HAGER BIOSCIENCES, INC.

Basic Information

116 RESEARCH DR, STE 265
BETHLEHEM, PA, 18015-4731

Company Profile

n/a

Additional Details

Field Value
DUNS: 828248745
Hubzone Owned: N
Socially and Economically Disadvantaged: Y
Woman Owned: N
Number of Employees: n/a


  1. MULTI-TARGETED COUNTERMEASURES AGAINST ACUTE AND DELAYED EFFECTS OF OP EXPOSURE

    Amount: $374,488.00

    DESCRIPTION (provided by applicant): Organophosphate (OP) nerve agents have been deployed as weapons of mass destruction in warfare arenas and in recent terrorist attacks; posing significant risks to ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. Developing Novel Dual CRF-R1/Orexin-1 Receptor Antagonists for Tobacco Dependence

    Amount: $299,973.00

    DESCRIPTION (provided by applicant): Tobacco use is now recognized as the single most responsible cause of avoidable death worldwide representing approximately 10% of all deaths globally. Directly or ...

    STTR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government